118 related articles for article (PubMed ID: 9415269)
1. Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants.
Padró T; Steins M; Li CX; Mesters RM; Hammel D; Scheld HH; Kienast J
Cardiovasc Res; 1997 Oct; 36(1):28-36. PubMed ID: 9415269
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries.
Steins MB; Padró T; Li CX; Mesters RM; Ostermann H; Hammel D; Scheld HH; Berdel WE; Kienast J
Atherosclerosis; 1999 Jul; 145(1):173-80. PubMed ID: 10428308
[TBL] [Abstract][Full Text] [Related]
3. Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteries.
Kienast J; Padró T; Steins M; Li CX; Schmid KW; Hammel D; Scheld HH; van de Loo JC
Thromb Haemost; 1998 Mar; 79(3):579-86. PubMed ID: 9531045
[TBL] [Abstract][Full Text] [Related]
4. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.
Padró T; Emeis JJ; Steins M; Schmid KW; Kienast J
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):893-902. PubMed ID: 7600121
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure.
Kauhanen P; Sirén V; Carpén O; Vaheri A; Lepäntalo M; Lassila R
Circulation; 1997 Sep; 96(6):1783-9. PubMed ID: 9323062
[TBL] [Abstract][Full Text] [Related]
6. Arterial expression of the plasminogen activator system early after cardiac transplantation.
Garvin MR; Labinaz M; Pels K; Walley VM; Mizgala HF; O'Brien ER
Cardiovasc Res; 1997 Aug; 35(2):241-9. PubMed ID: 9349387
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator system in human coronary atherosclerosis.
Raghunath PN; Tomaszewski JE; Brady ST; Caron RJ; Okada SS; Barnathan ES
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1432-43. PubMed ID: 7670959
[TBL] [Abstract][Full Text] [Related]
8. Localization of latent transforming growth factor-β binding protein-1 in human coronary atherosclerotic plaques.
Oklü R; Hesketh R; Wicky S; Metcalfe JC
Circ J; 2011; 75(1):196-200. PubMed ID: 21071877
[TBL] [Abstract][Full Text] [Related]
9. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.
Lupu F; Bergonzelli GE; Heim DA; Cousin E; Genton CY; Bachmann F; Kruithof EK
Arterioscler Thromb; 1993 Jul; 13(7):1090-100. PubMed ID: 7686395
[TBL] [Abstract][Full Text] [Related]
10. Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins.
Arnman V; Nilsson A; Stemme S; Risberg B; Rymo L
Thromb Res; 1994 Dec; 76(5):487-99. PubMed ID: 7900096
[TBL] [Abstract][Full Text] [Related]
11. [Expression of urokinase plasminogen activator, its receptor and plasminogen activator inhibitor type 1 in different types of atherosclerotic lesion in human aorta].
Solomatina MA; Plekhanova OS; Il'inskaia OP; Kalinina NI; Mikhaĭlova EV; Tsokolaeva ZI; Tararak EM; Naumov VG; Parfenova EV
Tsitologiia; 2004; 46(4):352-60. PubMed ID: 15346794
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions.
Steins MB; Padró T; Schwaenen C; Ruiz S; Mesters RM; Berdel WE; Kienast J
Blood Coagul Fibrinolysis; 2004 Jul; 15(5):383-91. PubMed ID: 15205586
[TBL] [Abstract][Full Text] [Related]
13. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.
Schneiderman J; Sawdey MS; Keeton MR; Bordin GM; Bernstein EF; Dilley RB; Loskutoff DJ
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6998-7002. PubMed ID: 1495992
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta.
Shireman PK; McCarthy WJ; Pearce WH; Patterson BK; Shively VP; Cipollone M; Tamarina N; Verrusio EN; Kwaan HC
J Vasc Surg; 1996 May; 23(5):810-7; discussion 817-8. PubMed ID: 8667502
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of plasminogen activator inhibitor-1 in human coronary atherosclerotic lesions involved in acute myocardial infarction.
Yorimitsu K; Saito T; Toyozaki T; Ishide T; Ohnuma N; Inagaki Y
Heart Vessels; 1993; 8(3):160-2. PubMed ID: 8407726
[TBL] [Abstract][Full Text] [Related]
16. C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo.
Kairuz EM; Barber MN; Anderson CR; Kanagasundaram M; Drummond GR; Woods RL
Cardiovasc Res; 2005 Jun; 66(3):574-82. PubMed ID: 15914122
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase.
O'Brien KD; Deeb SS; Ferguson M; McDonald TO; Allen MD; Alpers CE; Chait A
Am J Pathol; 1994 Mar; 144(3):538-48. PubMed ID: 8129039
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model.
de Waard V; Arkenbout EK; Carmeliet P; Lindner V; Pannekoek H
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1978-83. PubMed ID: 12482822
[TBL] [Abstract][Full Text] [Related]
19. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K
J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
[TBL] [Abstract][Full Text] [Related]
20. Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening.
Hasenstab D; Lea H; Clowes AW
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):853-9. PubMed ID: 10712413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
